EC grants orphan drug status for Santen's sirolimus to treat chronic non-infectious uveitis

Reviewed

From Santen Pharmaceutical Co., Ltd.Sep 8 2011

Santen Inc., the U.S. subsidiary of global ophthalmic pharmaceutical company Santen Pharmaceutical Co., Ltd. (Osaka, Japan) today announced the European Commission (EC) has granted orphan drug status for sirolimus (DE-109) for the treatment of chronic non-infectious uveitis. The designation follows a positive opinion from the Committee for Orphan Medicinal Products (COMP) within the European Medicines Agency (EMA) in June. Orphan designation will be published on the EMA website.

Source:

Santen Inc.

Posted in: Medical Condition News | Pharmaceutical News

Tags: Chronic, Pharmaceuticals, Rapamycin, Sirolimus, Stent, Transplant, Uveitis

Comments (0)

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

APA
Santen Pharmaceutical Co., Ltd.. (2020, February 01). EC grants orphan drug status for Santen's sirolimus to treat chronic non-infectious uveitis. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20110908/EC-grants-orphan-drug-status-for-Santens-sirolimus-to-treat-chronic-non-infectious-uveitis.aspx.
MLA
Santen Pharmaceutical Co., Ltd.. "EC grants orphan drug status for Santen's sirolimus to treat chronic non-infectious uveitis". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20110908/EC-grants-orphan-drug-status-for-Santens-sirolimus-to-treat-chronic-non-infectious-uveitis.aspx>.
Chicago
Santen Pharmaceutical Co., Ltd.. "EC grants orphan drug status for Santen's sirolimus to treat chronic non-infectious uveitis". News-Medical. https://www.news-medical.net/news/20110908/EC-grants-orphan-drug-status-for-Santens-sirolimus-to-treat-chronic-non-infectious-uveitis.aspx. (accessed November 21, 2024).
Harvard
Santen Pharmaceutical Co., Ltd.. 2020. EC grants orphan drug status for Santen's sirolimus to treat chronic non-infectious uveitis. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20110908/EC-grants-orphan-drug-status-for-Santens-sirolimus-to-treat-chronic-non-infectious-uveitis.aspx.